DrugSpace Symposium Spring 2022

Social Mixer and Workshop on the 2nd Day of the Symposium

Visit us in Gathertown

It's a small world!

The second virtual BioSolveIT DrugSpace Symposium revolves around the little gems of drug discovery: small molecules and fragments!
Experts from academia, the pharmaceutical industry, and academic institutions disclose current developments and unprecedented innovations to tackle future challenges in drug discovery. The symposium features interdisciplinary cross-talks between computational approaches, medicinal chemistry cases, crystallography, synthesis, small compound evolution, and the handling of molecular collections speedily.

Medicinal chemists, decision makers, representatives of any pharmaceutical- and medicine-related business, undergraduate and Ph.D. students, researchers, and everybody interested in future technologies and state-of-the-art drug development — you are cordially invited to participate in this virtual event. We will frame the Symposium with a virtual mixer in Gathertown so that also smaller circles can discuss, meet, and have a drink aside the presentations.

The DrugSpace Symposium takes place at 24-25th May 2022, and the registration is free-of-charge.

Confirmed Speakers

  • Xavier Barril (University of Barcelona)
    “A Bottom-Up Approach to Screening Massive Virtual Collections"
  • Adam Bond (University of Dundee)
    "Amide-to-Ester Substitution as a Strategy for Optimising PROTAC Permeability and Cellular Activity"
  • Esther Kellenberger (University of Strasbourg)
    "Analysis of Fragment Libraries"
  • Jeremy Edmunds (AbbVie)
    "Application of FastGrow to the Design and Synthesis of Drug Like Compounds"
  • Marcus Gastreich (BioSolveIT)
    "Zetta-Sized Chemical Space Navigation"
  • Sven Brüschweiler (MAG-LAB)
    "A Step toward NRF2‐DNA Interaction Inhibitors by Fragment‐Based NMR Methods"
  • Laurent Maveyraud (University of Toulouse)
    "Crystallographic Screening in FBDD: Application to the Phosphopantetheinyl Transferase of Mycobacterium Abscessus"
  • Paul Beroza (Genentech)
    "Chemical Space Docking: Large-Scale Structure-Based Virtual Screening for ROCK1 Inhibitors"
  • Peter Ertl (Novartis)
    "Magic Rings: Navigation in the Ring Chemical Space Guided by the Bioactive Rings"
  • Anna Hirsch (Helmholtz Institute for Pharmaceutical Research Saarland (HIPS))
    "Exploiting Fragment-Based Design in Anti-Infective Drug Discovery"

Programme

Download the line-up here:

Programme PDF

Symposium Workshop

To celebrate the event and the upcoming releases of our major platforms SeeSAR and infiniSee, we will feature an interactive workshop in our rebuilt Gathertown virtual office rooms.
The workshop starts on the second day of the symposium, 25th May 2022 at 3:00 pm (CEST) and will cover fragment-based ligand design (FBLD) with BioSolveIT applications.
Participants can use this opportunity for networking and discussing the topics of the Symposium.
Registration is not required but the space is limited — first come, first served principle. Please make sure to switch off any VPN connection to avoid connecting issues with Gathertown.
Visit us in Gathertown

First-Time BioSolveIT Disclosures

To celebrate the fragment-focussed DrugSpace Symposium 2022, we will announce powerful additions to our two major platforms SeeSAR and infiniSee that will augment every fragment-based drug discovery project.
Stay excited!
Chemical Space Club

Chemical Space Club

Enthusiasts of Chemical Spaces are invited to join the Chemical Space Club on LinkedIn.

Share information, early announcements, publications, success stories, and anything else related to huge chemistry spaces and databases. Become a member, and feel free to contribute.
Learn More

DrugSpace 2021 Recap: Recordings and Slides

Learn more

Latest BioSolveIT Updates

"A Gaze into Chemical Space" Series
April 16, 2024 11:26 CEST
Behind the Scenes of Enamine's REAL Space
April 15, 2024 16:43 CEST
category
Webinars
A Novel Class of SARS-CoV-2 Mpro Inhibitors: Systematic Design, Synthesis, Biological Evaluation, Antiviral Activity, and Structural Insights
Thu, 25 Apr 2024, 16:00 CEST (Berlin)